Reports for JAMP PHARMA CORPORATION
Company Name
JAMP PHARMA CORPORATION
Totals |
||
Shortage reports |
526 |
|
| Actual shortage: | 152 (29%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (0%) | |
| Resolved: | 373 (71%) | |
Discontinuation Reports |
14 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 14 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
125 (23%) |
|
Overdue reports |
82 (54%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2023-05-11 | 2023-08-03 | 192217 |
| JAMP-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2023-11-28 | 2023-12-18 | 211792 |
| JAMP-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2024-02-07 | 2024-03-18 | 218720 |
| JAMP-MYCOPHENOLATE CAPSULES | 250MG | CAPSULE | Resolved | 2024-02-07 | 2024-03-18 | 218727 |
| JAMP-NYSTATIN ORAL SUSPENSION USP | 100000UNIT | SUSPENSION | Resolved | 2019-10-11 | 2021-04-05 | 96198 |
| JAMP-NYSTATIN ORAL SUSPENSION USP | 100000UNIT | SUSPENSION | Resolved | 2019-10-11 | 2021-04-05 | 96202 |
| JAMP-NYSTATIN ORAL SUSPENSION USP | 100000UNIT | SUSPENSION | Actual shortage | 2023-04-12 | 2024-03-11 | 189373 |
| JAMP-NYSTATIN ORAL SUSPENSION USP | 100000UNIT | SUSPENSION | Actual shortage | 2023-11-28 | 2024-03-11 | 211795 |
| JAMP OLMESARTAN | 20MG | TABLET | Resolved | 2019-10-11 | 2022-12-09 | 96205 |
| JAMP OLMESARTAN | 40MG | TABLET | Resolved | 2019-10-11 | 2022-12-09 | 96208 |
| JAMP OLMESARTAN | 20MG | TABLET | Resolved | 2019-10-11 | 2022-12-09 | 96211 |
| JAMP OLMESARTAN | 40MG | TABLET | Resolved | 2019-10-11 | 2022-12-09 | 96215 |
| JAMP-OLOPATADINE | 0.1% | SOLUTION | Resolved | 2019-10-11 | 2021-08-31 | 96218 |
| JAMP-OLOPATADINE | 0.1% | SOLUTION | Actual shortage | 2023-08-24 | 2024-03-30 | 202886 |
| JAMP-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-04-06 | 2022-05-17 | 158143 |
| JAMP-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-01-20 | 2024-03-12 | 216850 |
| JAMP-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-01-20 | 2024-03-12 | 216853 |
| JAMP-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-01-20 | 2024-03-12 | 216856 |
| JAMP-ONDANSETRON | 2MG | SOLUTION | Resolved | 2017-03-30 | 2018-07-05 | 4839 |
| JAMP-ONDANSETRON | 2MG | SOLUTION | Resolved | 2017-03-30 | 2018-08-01 | 4842 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113293 |
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113296 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113299 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113302 |
| JAMP-ALPRAZOLAM | 1MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113305 |
| JAMP-ALPRAZOLAM | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113308 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168981 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168984 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168987 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168990 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168995 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168998 |
| JAMP-SILDENAFIL | 25.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169003 |
| JAMP-SILDENAFIL | 50.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169006 |
Showing 1 to 14 of 14